Earl D. Silverman

1983–2025 年に発表

115
論文数
17,928
被引用数
83
h 指数
114
i10 指数

被引用数

Earl D. Silverman の年別被引用数1985 年: 被引用 1 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 5 件1991 年: 被引用 2 件1992 年: 被引用 7 件1993 年: 被引用 13 件1994 年: 被引用 8 件1995 年: 被引用 10 件1996 年: 被引用 11 件1997 年: 被引用 13 件1998 年: 被引用 15 件1999 年: 被引用 16 件2000 年: 被引用 29 件2001 年: 被引用 34 件2002 年: 被引用 49 件2003 年: 被引用 60 件2004 年: 被引用 77 件2005 年: 被引用 109 件2006 年: 被引用 76 件2007 年: 被引用 93 件2008 年: 被引用 115 件2009 年: 被引用 134 件2010 年: 被引用 186 件2011 年: 被引用 186 件2012 年: 被引用 153 件2013 年: 被引用 114 件2014 年: 被引用 115 件2015 年: 被引用 122 件2016 年: 被引用 119 件2017 年: 被引用 104 件2018 年: 被引用 150 件2019 年: 被引用 437 件2020 年: 被引用 358 件2021 年: 被引用 353 件2022 年: 被引用 267 件2023 年: 被引用 154 件2024 年: 被引用 257 件2025 年: 被引用 83 件2026 年: 被引用 3 件1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,264 件、この内訳の 23.4%イギリス: 引用元論文 480 件、この内訳の 8.9%カナダ: 引用元論文 451 件、この内訳の 8.4%イタリア: 引用元論文 324 件、この内訳の 6%ドイツ: 引用元論文 268 件、この内訳の 5%中国: 引用元論文 198 件、この内訳の 3.7%オランダ: 引用元論文 190 件、この内訳の 3.5%フランス: 引用元論文 188 件、この内訳の 3.5%スペイン: 引用元論文 135 件、この内訳の 2.5%オーストラリア: 引用元論文 117 件、この内訳の 2.2%スウェーデン: 引用元論文 102 件、この内訳の 1.9%ブラジル: 引用元論文 101 件、この内訳の 1.9%
0%23.4%その他 29.1%

分野

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology5.6%
  • Neuroscience1.3%
  • Health Professions0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • その他0.8%

トピック

  • Systemic Lupus Erythematosus Research10.9%
  • Autoimmune and Inflammatory Disorders Research8.3%
  • Rheumatoid Arthritis Research and Therapies4.6%
  • Adolescent and Pediatric Healthcare3%
  • Ocular Diseases and Behçet’s Syndrome2.8%
  • Genomics and Rare Diseases2.8%
  • その他67.6%

共著者

全論文

検索で開く
  1. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saadet Mercimek‐Andrews, Roberto Mendoza‐Londono, Tino D. Piscione, Rayfel Schneider, Andreas Schulze, Earl D. Silverman, Komudi Siriwardena, O. Carter Snead, Neal Sondheimer, Joanne Sutherland, Ajoy Vincent, Jonathan D. Wasserman, Rosanna Weksberg, Cheryl Shuman, Chris Carew, Michael J. Szego, Robin Z. Hayeems, Raveen Basran, Dimitri J. Stavropoulos, Peter N. Ray, Sarah Bowdin, M. Stephen Meyn, Ronald D. Cohn, Stephen W. Scherer, Christian R. Marshall - Genetics in Medicine 2017 被引用: 565

  2. Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus

    著者: , , , , - Arthritis & Rheumatism 2008 被引用: 556

  3. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty ほか 10 名 - Nature Genetics 2015 被引用: 388

  4. Prevalence and burden of pediatric-onset systemic lupus erythematosus

    著者: , - Nature Reviews Rheumatology 2010 被引用: 358

  5. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase

    著者: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 185

  6. Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study

    著者: , , , , , - The Journal of Pediatrics 2007 被引用: 368

  7. The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus

    著者: , , , , - Journal of the American College of Cardiology 2010 被引用: 269

  8. Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood‐Onset Systemic Lupus Erythematosus

    著者: , , , , - Arthritis & Rheumatology 2018 被引用: 95

  9. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE

    著者: , , , , , , , , , , , - Lara D. Veeken 2019 被引用: 58

  10. Use of atorvastatin in systemic lupus erythematosus in children and adolescents

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2011 被引用: 173

  11. Ethnic Differences in Pediatric Systemic Lupus Erythematosus

    著者: , , , , , - The Journal of Rheumatology 2009 被引用: 173

  12. Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Rheumatology 2020 被引用: 34

  13. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis

    著者: , , , , , , , , , - The Journal of Rheumatology 2020 被引用: 28

  14. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graciela Espada, Roger Allen, Jeffrey Chaitow, Rik Joos, Carine Wouters, Sheila Knupp, Flavio Sztajnbok, David Cabral, Kristin Houghton, Johannes Roth, Heinrike Schmeling, Chantal Job-Deslandre, Christian Jorgensen, Isabelle Kone Paut, Kirsten Minden, Frank Weller-Heinemann, Valeria Gerloni, Francesco Zulian, Ruben Burgos-Vargas, Carolina Duarte Salazar, Eunice Solis-Vallejo, Armando Calvo, José Chavez, Manuel Ferrandiz Zavaler, Anna Gruenpeter, Katarzyna Kobusinska, Alexey Sarychev, Elena Zholobova, Athimalaipet Ramanan, Patricia Woo, Steven Goodman, Abraham Gedalia, Yukiko Kimura, Karen Onel, Kenneth Schikler - Annals of the Rheumatic Diseases 2014 被引用: 314

  15. The role of antimalarial agents in the treatment of SLE and lupus nephritis

    著者: , , - Nature Reviews Nephrology 2011 被引用: 242

  16. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ornella J. Rullo, Natasha M. Ruth, Laura E. Schanberg, Earl D. Silverman, Nora G. Singer, Jennifer B. Soep, Reema Syed, Larry B. Vogler, Ali Yalçindağ, Cagri Yildirim‐Toruner, Carol A. Wallace, Hermine I. Brunner - Arthritis Care & Research 2011 被引用: 194

  17. A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo A. Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini, Edward H. Giannini - Arthritis & Rheumatism 2007 被引用: 411

  18. Risk factors for damage in childhood‐onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage

    著者: , , , , - Arthritis & Rheumatism 2002 被引用: 318

  19. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor

    著者: , , , , , , - Arthritis & Rheumatism 2007 被引用: 285

  20. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 240

  21. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel J. Lovell, Alberto Martini - Annals of the Rheumatic Diseases 2017 被引用: 128

  22. Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    著者: , , , , , , , , , , , - New England Journal of Medicine 2000 被引用: 1,252

  23. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long‐term followup study

    著者: , , , , , , - Arthritis & Rheumatism 2007 被引用: 289

  24. Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodies

    著者: , , , - The Journal of Pediatrics 2003 被引用: 282